<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">KJO</journal-id>
      <journal-title-group>
        <journal-title>Korean Journal of Ophthalmology : KJO</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8942</issn>
      <issn pub-type="epub">2092-9382</issn>
      <publisher>
        <publisher-name>The Korean Ophthalmological Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22323887</article-id>
      <article-id pub-id-type="pmc">3268170</article-id>
      <article-id pub-id-type="doi">10.3341/kjo.2012.26.1.54</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Intraocular Involvement of a Nasal Natural Killer T-Cell Lymphoma: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yoo</surname>
            <given-names>Jae Ho</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Soo Young</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Kyu Bong</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jung Joo</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Sang Joon</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Ophthalmology, Kosin University College of Medicine, Busan, Korea.</aff>
      <author-notes>
        <corresp>
Corresponding Author: Sang Joon Lee, MD. Department of Ophthalmology, Gospel Hospital, Kosin University College of Medicine, #34 Amnam-dong, Seo-gu, Busan 602-702, Korea. Tel: 82-51-990-6140, Fax: 82-51-990-3026, <email>hiatus@ns.kosinmed.co.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>1</month>
        <year>2012</year>
      </pub-date>
      <volume>26</volume>
      <issue>1</issue>
      <fpage>54</fpage>
      <lpage>57</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>2</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2012 The Korean Ophthalmological Society</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Herein, we report a case of nasal natural killer T-cell lymphoma (NKTL) with intraocular involvement. A 57-year-old woman was referred due to a three-day history of photophobia and diplopia in the left eye. One-month previously, she was diagnosed with nasal NKTL of the right nasal cavity. Ophthalmic examination revealed conjunctival injection and ptosis. The left pupil was fully dilated and non-reactive to light. Ocular motion was restricted on left-upper gaze. Five days later, anterior uveitis developed and persisted despite topical steroid treatment. An orbital magnetic resonance imaging was without specific findings, however, ophthalmoplegia, vitreous opacity, and an iris mass were observed. A diagnostic anterior chamber aspiration was performed. Aqueous humor aspiration revealed 35% morphologically atypical lymphocytes. After an intravitreal triamcinolone injection, radiotherapy and chemotherapy were administered; this resolved the uveitis and iris mass. When refractory uveitis or orbital pseudotumor occurs in patients with nasal NKTL, ocular and orbital involvement of the NKTL should be considered.</p>
      </abstract>
      <kwd-group>
        <kwd>Extranodal NK-T-cell lymphoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Malignant lymphomas that develop in the orbit and ocular adnexa account for 8% of all extranodal lymphomas [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Most ocular and orbital lymphomas are non-Hodgkin's B-cell lymphoma [<xref ref-type="bibr" rid="B1">1</xref>]. At these sites, with the exception of B-cell lymphoma, lymphoblastic diseases are rare and occur in only 1% to 3% of cases [<xref ref-type="bibr" rid="B2">2</xref>]. Ocular and ocular adnexa T-cell lymphomas are rare. There are few cases of nasal natural killer T-cell lymphoma (NKTL) reported in the medical literature [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Additionally, pathologically confirmed intraocular involvement of nasal NKTL, such as the case reported here, is very rare [<xref ref-type="bibr" rid="B3">3</xref>].</p>
    <sec>
      <title>Case Report</title>
      <p>A 57-year-old woman presented with a three-day history of photophobia and diplopia in the left eye. She was diagnosed with histologically confirmed nasal NKTL of the right nasal cavity one month prior. The Snellen visual acuity of the affected eye with correction was 1.0 / 0.63, and the intraocular pressure in the right and left eyes was 17 and 18 mmHg, respectively. The patient had mild left eye conjunctival injection, ptosis, and swelling of the eyelid. The left pupil was fully dilated with no pupillary light reflex. Ocular movement on left-upper gaze was limited in the left eye. Five days later, the left corrected visual acuity deteriorated and ptosis worsened. Slit lamp examination revealed anterior uveitis refractory to topical steroid treatment. Opthalmoplegia, vitreous opacity, and an iris mass developed in the left eye (<xref ref-type="fig" rid="F1">Fig. 1A and 1B</xref>). Orbital magnetic resonance imaging and cerebrospinal fluid investigations were unremarkable. Aqueous humor aspiration from the anterior chamber was performed with a 26-gauge needle. Thirty-five percent of the cells obtained from the aspiration were morphologically atypical lymphocytes.</p>
      <p>The patient was diagnosed with intraocular dissemination of the lymphoma. Treatment with intravitreal triamcinolone injections, radiotherapy, and chemotherapy was administered. Skin manifestations of the lymphoma were noted 40 days post-chemotherapy (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Skin biopsy confirmed neoplastic infiltration of small- to medium-sized pleomorphic lymphocytes with irregular nuclei, inconspicuous nucleoli, and scant cytoplasm (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Immunohistochemical staining was positive for CD56 (<xref ref-type="fig" rid="F2">Fig. 2C</xref>) and CD3 (<xref ref-type="fig" rid="F2">Fig. 2D</xref>). The patient was diagnosed with nasal NKTL with ocular involvement. After receiving radiotherapy at 900 cGy, her visual acuity improved and her anterior uveitis, vitreous opacity, and iris mass resolved (<xref ref-type="fig" rid="F3">Fig. 3A and 3B</xref>). However, the patient's condition continued to deteriorate despite radiotherapy and chemotherapy, and her ptosis and ophthalmoplegia gradually progressed. She died of sepsis three months after diagnosis.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Extranodal NKTL, including nasal NKTL, previously known as lethal midline granuloma, is a definitive diagnostic entity according to the World Health Organization lymphoma classification [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The nasal cavity is the most common site of involvement. However, histopathologically identical tumors may be identified at other extranodal sites, including the skin, muscle, gastrointestinal tract, liver, kidney, and retroperitoneal space [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Orbital and adnexal involvement has been infrequently reported in patients with this disorder [<xref ref-type="bibr" rid="B6">6</xref>]. There are few reported cases of nasal NKTL involving the orbit and/or ocular adnexa [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Coupland et al. [<xref ref-type="bibr" rid="B2">2</xref>] and Woog et al. [<xref ref-type="bibr" rid="B6">6</xref>] reported the formation of chronic uveitis and vitritis as intraocular manifestations of NKTL. Cimino et al. [<xref ref-type="bibr" rid="B3">3</xref>] did report a case of histologically confirmed nasal NKTL with intraocular involvement, however, in most cases intraocular involvement has not been confirmed histologically. The presence of intraocular involvement raises the possibility of leptomeningeal or central nervous system dissemination, and prompts consideration for external-beam radiotherapy to the eye and orbit in addition to systemic chemotherapy [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. NKTL involving the ocular adnexa is generally a rapidly progressing disease, with a short survival from time of diagnosis, despite standard therapy [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. This was true in the current case as well; the patient died three months after diagnosis. Since NKTL with ocular and orbital involvement is very rare and is characterized by rapid disease progression and a poor prognosis, NKTL should be considered in the differential diagnosis of uveitis or orbital pseudotumor refractory to therapy.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflict of interest relevant to this article was reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Suh</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YD</given-names>
            </name>
          </person-group>
          <article-title>Nasal-type natural killer/T-cell lymphoma of the orbit</article-title>
          <source>J Korean Ophthalmol Soc</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>2145</fpage>
          <lpage>2150</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coupland</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Delecluse</surname>
              <given-names>HJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume>105</volume>
          <fpage>1430</fpage>
          <lpage>1441</lpage>
          <pub-id pub-id-type="pmid">9709754</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cimino</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ocular involvement in nasal natural killer T-cell lymphoma</article-title>
          <source>Int Ophthalmol</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>275</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="pmid">18438613</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kwok</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Shek</surname>
              <given-names>TW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vision-threatening complications of nasal T/NK lymphoma</article-title>
          <source>Am J Ophthalmol</source>
          <year>2002</year>
          <volume>134</volume>
          <fpage>406</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="pmid">12208253</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Hakeem</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Fedele</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carlos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Extranodal NK/T-cell lymphoma, nasal type</article-title>
          <source>Oral Oncol</source>
          <year>2007</year>
          <volume>43</volume>
          <fpage>4</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">17064952</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woog</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Yeatts</surname>
              <given-names>RP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Natural killer/T-cell lymphoma with ocular and adnexal involvement</article-title>
          <source>Ophthalmology</source>
          <year>2006</year>
          <volume>113</volume>
          <fpage>140</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">16360212</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Suchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Koshikawa</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract</article-title>
          <source>Am J Surg Pathol</source>
          <year>1995</year>
          <volume>19</volume>
          <fpage>284</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">7532919</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheung</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>WH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients</article-title>
          <source>J Clin Oncol</source>
          <year>1998</year>
          <volume>16</volume>
          <fpage>70</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">9440725</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Sin</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm</article-title>
          <source>Blood</source>
          <year>1997</year>
          <volume>89</volume>
          <fpage>4501</fpage>
          <lpage>4513</lpage>
          <pub-id pub-id-type="pmid">9192774</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Natural killer cell neoplasms</article-title>
          <source>Anat Pathol</source>
          <year>1998</year>
          <volume>3</volume>
          <fpage>77</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">10389582</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>(A) Fundoscopy revealed vitreous haziness and opacity. (B) Slit lamp exam revealed a nodular, depigmented, mass-like appearance of the iris (black arrow) and a pinkish lump in the iris (white arrow).</p>
      </caption>
      <graphic xlink:href="kjo-26-54-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>(A) This photograph demonstrates multiple erythematous and violaceous, well-defined, coin-sized plaques and nodules in the lower limbs. (B) The neoplastic infiltrate was composed of small- to medium-sized pleomorphic lymphocytes with irregular nuclei, inconspicuous nucleoli, and scant cytoplasm. (C) Immunotype was CD56+. (D) Immunotype was CD3+.</p>
      </caption>
      <graphic xlink:href="kjo-26-54-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>(A) Vitreous opacity resolved after radiotherapy at 900 cGy. (B) The iris masses resolved after radiotherapy at 900 cGy.</p>
      </caption>
      <graphic xlink:href="kjo-26-54-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
